Ohcanbohtosat - Merchant, Kalpana

Developing Therapeutics for Schizophrenia and Other Psychotic Disorders Dahkki Marek, Gerard, Merchant, Kalpana

Viečča ollesdeavstta Viečča ollesdeavstta

Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders Dahkki Schadt, Eric E., Buchanan, Sean, Brennand, Kristen J., Merchant, Kalpana M.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients Dahkki Ysselstein, Daniel, Nguyen, Maria, Young, Tiffany J., Severino, Alex, Schwake, Michael, Merchant, Kalpana, Krainc, Dimitri

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Urinary proteome profiling for stratifying patients with familial Parkinson’s disease Dahkki Virreira Winter, Sebastian, Karayel, Ozge, Strauss, Maximilian T, Padmanabhan, Shalini, Surface, Matthew, Merchant, Kalpana, Alcalay, Roy N, Mann, Matthias

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic Development Dahkki Alcalay, Roy N., Hsieh, Frank, Tengstrand, Elizabeth, Padmanabhan, Shalini, Baptista, Marco, Kehoe, Caitlin, Narayan, Sushma, Boehme, Amelia K., Merchant, Kalpana

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry Dahkki Kellie, John F., Higgs, Richard E., Ryder, John W., Major, Anthony, Beach, Thomas G., Adler, Charles H., Merchant, Kalpana, Knierman, Michael D.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease Dahkki Karayel, Ozge, Virreira Winter, Sebastian, Padmanabhan, Shalini, Kuras, Yuliya I., Vu, Duc Tung, Tuncali, Idil, Merchant, Kalpana, Wills, Anne-Marie, Scherzer, Clemens R., Mann, Matthias

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease Dahkki Surface, Matthew, Balwani, Manisha, Waters, Cheryl, Haimovich, Alexander, Gan‐Or, Ziv, Marder, Karen S., Hsieh, Tammy, Song, Linxia, Padmanabhan, Shalini, Hsieh, Frank, Merchant, Kalpana M., Alcalay, Roy N.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

The Parkinson’s disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites Dahkki Greggio, Elisa, Taymans, Jean-Marc, Zhen, Eugene Yuejun, Ryder, John, Vancraenenbroeck, Renée, Beilina, Alexandra, Sun, Peng, Deng, Junpeng, Jaffe, Howard, Baekelandt, Veerle, Merchant, Kalpana, Cookson, Mark R.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression Dahkki Concha‐Marambio, Luis, Farris, Carly M., Holguin, Bret, Ma, Yihua, Seibyl, John, Russo, Marco J., Kang, Un J., Hutten, Samantha J., Merchant, Kalpana, Shahnawaz, Mohammad, Soto, Claudio

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Translating Glutamate: From Pathophysiology to Treatment Dahkki Javitt, Daniel C., Schoepp, Darryle, Kalivas, Peter W., Volkow, Nora D., Zarate, Carlos, Merchant, Kalpana, Bear, Mark F., Umbricht, Daniel, Hajos, Mihaly, Potter, William Z., Lee, Chi-Ming

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Targeting α-synuclein for treating Parkinson’s disease: mechanistic and therapeutic considerations Dahkki Dehay, Benjamin, Bourdenx, Mathieu, Gorry, Philippe, Przedborski, Serge, Vila, Miquel, Hunot, Stephane, Singleton, Andrew, Olanow, C. Warren, Merchant, Kalpana M., Bezard, Erwan, Petsko, Gregory A., Meissner, Wassilios G.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Gain and loss of function of P2X(7) receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain Dahkki Ursu, Daniel, Ebert, Philip, Langron, Emily, Ruble, Cara, Munsie, Leanne, Zou, Wei, Fijal, Bonnie, Qian, Yue-Wei, McNearney, Terry A, Mogg, Adrian, Grubisha, Olivera, Merchant, Kalpana, Sher, Emanuele

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Biochemical and Morphological Consequences of Human α-Synuclein Expression in a Mouse α-Synuclein Null Background Dahkki Prasad, Kavita, Tarasewicz, Elizabeth, Strickland, Pamela A. Ohman, O’Neill, Michael, Mitchell, Stephen N., Merchant, Kalpana, Tep, Samnang, Hilton, Kathryn, Datwani, Akash, Buttini, Manuel, Mueller-Steiner, Sarah, Richfield, Eric K.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Biomarkers for the Development of New Medications for Cocaine Dependence Dahkki Bough, Kristopher J, Amur, Shashi, Lao, Guifang, Hemby, Scott E, Tannu, Nilesh S, Kampman, Kyle M, Schmitz, Joy M, Martinez, Diana, Merchant, Kalpana M, Green, Charles, Sharma, Jyoti, Dougherty, Anne H, Moeller, F Gerard

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein Dahkki Merchant, Kalpana M., Cedarbaum, Jesse M., Brundin, Patrik, Dave, Kuldip D., Eberling, Jamie, Espay, Alberto J., Hutten, Samantha J., Javidnia, Monica, Luthman, Johan, Maetzler, Walter, Menalled, Liliana, Reimer, Alyssa N., Stoessl, A. Jon, Weiner, David M.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts Dahkki Padmanabhan, Shalini, Lanz, Thomas A., Gorman, Donal, Wolfe, Michele, Joyce, Alison, Cabrera, Carlos, Lawrence-Henderson, Rosemary, Levers, Najah, Joshi, Neal, Ma, Thong C., Liong, Christopher, Narayan, Sushma, Alcalay, Roy N., Hutten, Samantha J., Baptista, Marco A.S., Merchant, Kalpana

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations Dahkki Mollenhauer, Brit, Batrla, Richard, El‐Agnaf, Omar, Galasko, Douglas R., Lashuel, Hilal A., Merchant, Kalpana M., Shaw, Lesley M., Selkoe, Dennis J., Umek, Robert, Vanderstichele, Hugo, Zetterberg, Henrik, Zhang, Jing, Caspell‐Garcia, Chelsea, Coffey, Chris, Hutten, Samantha J., Frasier, Mark, Taylor, Peggy

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial Dahkki Simuni, Tanya, Fiske, Brian, Merchant, Kalpana, Coffey, Christopher S., Klingner, Elizabeth, Caspell-Garcia, Chelsea, Lafontant, David-Erick, Matthews, Helen, Wyse, Richard K., Brundin, Patrik, Simon, David K., Schwarzschild, Michael, Weiner, David, Adams, Jamie, Venuto, Charles, Dawson, Ted M., Baker, Liana, Kostrzebski, Melissa, Ward, Tina, Rafaloff, Gary

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients Dahkki Alcalay, Roy N., Wolf, Pavlina, Chiang, Ming Sum Ruby, Helesicova, Karolina, Zhang, Xiaokui Kate, Merchant, Kalpana, Hutten, Samantha J., Scherzer, Clemens, Caspell‐Garcia, Chelsea, Blauwendraat, Cornelis, Foroud, Tatiana, Nudelman, Kelly, Gan‐Or, Ziv, Simuni, Tanya, Chahine, Lana M., Levy, Oren, Zheng, Dandi, Li, Gen, Sardi, Sergio Pablo

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta